A phase I, pharmacokinetic, and pharmacodynamic evaluation of the DNA methyltransferase inhibitor 5-fluoro-2′-deoxycytidine, administered with tetrahydrouridine
Crossref DOI link: https://doi.org/10.1007/s00280-014-2674-7
Published Online: 2015-01-08
Published Print: 2015-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Newman, Edward M.
Morgan, Robert J.
Kummar, Shivaani
Beumer, Jan H.
Blanchard, M. Suzette
Ruel, Christopher
El-Khoueiry, Anthony B.
Carroll, Mary I.
Hou, Jessie M.
Li, Chun
Lenz, Heinz J.
Eiseman, Julie L.
Doroshow, James H.
Text and Data Mining valid from 2015-01-08